These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 27652593

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience.
    Kataruka A, Kong X, Haymart B, Kline-Rogers E, Almany S, Kozlowski J, Krol GD, Kaatz S, McNamara MW, Froehlich JB, Barnes GD.
    Vasc Med; 2017 Jun; 22(3):197-203. PubMed ID: 28145152
    [Abstract] [Full Text] [Related]

  • 25. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
    Barnes GD, Kong X, Cole D, Haymart B, Kline-Rogers E, Almany S, Dahu M, Ekola M, Kaatz S, Kozlowski J, Froehlich JB.
    J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
    [Abstract] [Full Text] [Related]

  • 26. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA, CATCH Investigators.
    JAMA; 2015 Aug 18; 314(7):677-686. PubMed ID: 26284719
    [Abstract] [Full Text] [Related]

  • 27. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
    Zakai NA, Walker RF, MacLehose RF, Adam TJ, Alonso A, Lutsey PL.
    J Thromb Haemost; 2018 Dec 18; 16(12):2403-2412. PubMed ID: 30240508
    [Abstract] [Full Text] [Related]

  • 28. Triple therapy after PCI - Warfarin treatment quality and bleeding risk.
    Wadell D, Jensen J, Englund E, Själander A.
    PLoS One; 2018 Dec 18; 13(12):e0209187. PubMed ID: 30562365
    [Abstract] [Full Text] [Related]

  • 29. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C, Alotaibi GS, Alsaleh K, Sean McMurtry M.
    Thromb Res; 2014 Sep 18; 134(3):627-32. PubMed ID: 25047174
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB, Skjøth F, Kjældgaard JN, Lip GYH, Nielsen PB, Søgaard M.
    Lancet Haematol; 2017 May 18; 4(5):e237-e244. PubMed ID: 28411120
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.